Fowl Cholera: Causal Agent (Pasteurella multocida) and Disease Management in Poultry

Etiology and the Fowl Cholera Causal Agent

Fowl cholera, also termed avian pasteurellosis, is a contagious bacterial disease of domestic and wild birds caused by the Gram-negative coccobacillus Pasteurella multocida. The fowl cholera causal agent is classified within the family Pasteurellaceae and is characterized by its bipolar staining properties when treated with methylene blue or Giemsa stains [1]. P. multocida is a facultative anaerobe that grows optimally at 37 degrees Celsius on blood agar or dextrose starch agar, producing small, dew-drop colonies with a characteristic odor [1]. The organism possesses a polysaccharide capsule that serves as a major virulence factor, and five capsular serogroups (A, B, D, E, F) are recognized based on capsular antigens [2]. In poultry, serogroups A and D are most frequently isolated from clinical cases of fowl cholera [2, 3]. Somatic lipopolysaccharide antigens further classify the bacterium into 16 serotypes (1 through 16) using the Heddleston typing scheme, with serotypes 1, 3, and 4 commonly associated with avian disease [3].

The fowl cholera causal agent produces several virulence determinants including a dermonecrotic toxin (DNT), fimbriae, and outer membrane proteins that facilitate adhesion to host epithelial cells [4]. The capsule inhibits phagocytosis by avian macrophages, while the lipopolysaccharide layer triggers a strong inflammatory response that contributes to the acute septicemic form of the disease [4, 5]. Strains of P. multocida isolated from poultry may also produce neuraminidase and hyaluronidase, enzymes that degrade host connective tissue and promote bacterial dissemination [5].

Epidemiology and Host Range

Fowl cholera affects a wide range of avian species including chickens, turkeys, ducks, geese, and game birds [1, 6]. Turkeys are particularly susceptible and often experience higher morbidity and mortality rates compared to chickens [6]. The disease occurs worldwide and is most prevalent in regions with intensive poultry production systems [1]. Outbreaks are often associated with stress factors such as overcrowding, poor ventilation, nutritional deficiencies, or concurrent infections [7].

Transmission occurs primarily through horizontal routes. Carrier birds, including recovered poultry and asymptomatic wild birds, serve as reservoirs and shed the organism in oral and nasal secretions [6, 7]. Contaminated feed, water, and fomites facilitate indirect transmission [1]. The bacterium can survive for several days in organic material, water, and soil under favorable conditions of moisture and moderate temperature [7]. Vertical transmission via the egg is not considered a significant route of spread [1].

The incubation period ranges from 24 to 72 hours following exposure [6]. In acute outbreaks, mortality can reach 50 percent or higher in susceptible flocks, particularly in turkeys [1, 6]. Chronic infections may persist in flocks for weeks or months, with low-level mortality and reduced production performance [7].

Pathogenesis

Following inhalation or ingestion, P. multocida colonizes the upper respiratory tract mucosa [4]. The bacterium adheres to pharyngeal and tonsillar epithelium via fimbriae and outer membrane adhesins [4, 5]. Once established, the organism invades the submucosa and enters the bloodstream, leading to a fulminant septicemia [4]. The polysaccharide capsule confers resistance to complement-mediated killing and phagocytosis, allowing rapid bacterial proliferation in the blood and internal organs [5].

The lipopolysaccharide component triggers the release of pro-inflammatory cytokines including tumor necrosis factor-alpha and interleukins, resulting in vascular permeability, disseminated intravascular coagulation, and multi-organ failure [5]. In chronic infections, the bacterium localizes to synovial membranes, wattles, conjunctiva, and respiratory tissues, where it induces a granulomatous inflammatory response [4, 7].

Clinical Signs

Clinical presentation varies with the course of infection. The peracute form is characterized by sudden death in apparently healthy birds, often without premonitory signs [1, 6]. In acute fowl cholera, affected birds exhibit fever (elevated body temperature), depression, anorexia, ruffled feathers, and cyanosis of the comb and wattles [1, 6]. Respiratory signs include dyspnea, rales, and mucoid nasal discharge [7]. Diarrhea, initially watery and later becoming greenish or blood-tinged, is common [1]. Oral and nasal mucous membranes may show petechial hemorrhages [6].

Chronic fowl cholera presents with localized infections. Wattle swelling (wattle edema) is a classic sign in chickens, often progressing to caseous necrosis and abscess formation [1, 7]. Synovitis and arthritis cause lameness and reluctance to move [6]. Torticollis (twisted neck) may occur due to meningeal involvement or otitis media [7]. Conjunctivitis and sinusitis with purulent exudate are also observed [1]. In laying flocks, egg production drops sharply [6].

Pathology

Gross lesions in acute fowl cholera reflect a septicemic process. Petechial and ecchymotic hemorrhages are present on the epicardium, serosal surfaces, and abdominal fat [1, 6]. The liver is enlarged, friable, and exhibits multiple small, pale necrotic foci (miliary necrosis) [1, 7]. The spleen is swollen and congested [6]. The lungs may be edematous and congested, and the trachea may contain frothy exudate [7]. Intestinal mucosa shows catarrhal to hemorrhagic enteritis [1].

In chronic cases, localized lesions predominate. Caseous material fills the wattles, and fibrinous to purulent exudate is found in the joints, tendon sheaths, and periarticular tissues [1, 6]. The conjunctival sacs and infraorbital sinuses may contain inspissated pus [7]. Pneumonia and airsacculitis with fibrinous exudate are common in turkeys [6].

Histopathological examination reveals acute necrotizing hepatitis with multifocal coagulative necrosis and infiltration of heterophils [4]. Splenic white pulp is depleted, and the red pulp contains numerous bacterial emboli [4, 5]. In chronic lesions, granulomatous inflammation with central caseous necrosis surrounded by epithelioid macrophages and multinucleated giant cells is observed [4].

Diagnostics

Definitive diagnosis of fowl cholera requires isolation and identification of P. multocida from affected tissues [1, 3]. Samples for culture include liver, spleen, bone marrow, heart blood, and wattle exudate [1, 6]. Swabs from the oropharynx or trachea may be collected from live birds [7].

Direct microscopy of tissue impression smears stained with methylene blue or Giemsa reveals characteristic bipolar staining coccobacilli, providing a rapid presumptive diagnosis [1, 3]. Culture on blood agar or MacConkey agar (the organism does not grow on MacConkey) under aerobic conditions at 37 degrees Celsius yields colonies within 24 to 48 hours [1]. P. multocida is identified by its colony morphology, Gram-negative staining, positive catalase and oxidase reactions, and indole production [3]. Biochemical profiling using commercial identification systems confirms the species [3].

Serotyping is performed using the capsular typing method (hyaluronidase inhibition test for serogroup A) or the Heddleston somatic antigen gel diffusion precipitin test [2, 3]. Molecular diagnostics, including polymerase chain reaction (PCR) assays targeting the kmt1 gene (species-specific) and capsular typing genes, offer rapid and sensitive detection directly from clinical samples [3, 8]. Real-time PCR assays can quantify bacterial load and differentiate serogroups [8]. Whole genome sequencing may be employed for epidemiological tracing and antimicrobial resistance gene profiling [8].

Differential diagnoses include other causes of acute septicemia in poultry such as Salmonella Gallinarum (fowl typhoid), Salmonella Pullorum (pullorum disease), Escherichia coli (colibacillosis), and Erysipelothrix rhusiopathiae (erysipelas) [1, 6]. Chronic forms must be differentiated from Mycoplasma gallisepticum infection, infectious coryza (Avibacterium paragallinarum), and aspergillosis [7].

Treatment

Antimicrobial therapy is the cornerstone of treatment for acute outbreaks [1, 6]. P. multocida is generally susceptible to a range of antibiotics including tetracyclines, sulfonamides, penicillin, ampicillin, ceftiofur, enrofloxacin, and florfenicol [1, 7]. However, antimicrobial susceptibility testing should be performed on isolated strains due to the emergence of resistance [7, 9]. Tetracyclines (e.g., chlortetracycline or oxytetracycline) administered in feed or drinking water at therapeutic doses are commonly used for flock-level treatment [1]. Sulfadimethoxine and sulfamethazine combinations are also effective [6].

Water-soluble antibiotics such as enrofloxacin or florfenicol provide rapid intervention in severely affected flocks [7]. Treatment duration typically ranges from 5 to 7 days [1]. In chronic cases with localized abscesses, surgical drainage of wattle lesions combined with systemic antibiotics may be necessary [6].

Antimicrobial resistance in P. multocida from poultry has been reported against tetracyclines, sulfonamides, and beta-lactams [9]. Resistance genes such as tet(B), tet(H), sul2, and blaROB-1 have been identified in avian isolates [9]. Prudent antimicrobial use and routine susceptibility surveillance are essential to preserve therapeutic efficacy [7, 9].

Control and Prevention

Control of fowl cholera relies on biosecurity, management practices, and vaccination [1, 6]. Biosecurity measures include preventing contact between domestic poultry and wild birds, controlling rodent and fomite transmission, and implementing all-in/all-out production systems [1, 7]. Cleaning and disinfection of poultry houses with agents effective against P. multocida (e.g., quaternary ammonium compounds, sodium hypochlorite, or formaldehyde) is critical following an outbreak [6].

Carrier birds should be identified and culled to eliminate the reservoir [1]. In breeding flocks, serological monitoring using enzyme-linked immunosorbent assays (ELISAs) can detect carrier status [3]. Stress reduction through proper ventilation, nutrition, and stocking density reduces disease susceptibility [7].

Vaccination is a key component of long-term control [1, 10]. Both inactivated (bacterin) and live attenuated vaccines are available for poultry [10]. Bacterins are typically multivalent, containing multiple serotypes of P. multocida (commonly serotypes 1, 3, and 4) and are administered via subcutaneous or intramuscular injection [1, 10]. Two doses given 2 to 4 weeks apart are recommended, with annual boosters [10]. Live vaccines, such as the CU (Clemson University) strain, are administered via drinking water or wing-web stab and provide broader cross-protection [10]. However, live vaccines retain some virulence and may cause disease in turkeys or immunocompromised birds [10].

Autogenous vaccines prepared from the specific outbreak strain may be used when commercial vaccines fail to provide adequate protection [1]. Vaccine efficacy is influenced by serotype matching, adjuvant type, and flock immune status [10].

The following table summarizes key control measures for fowl cholera in poultry.

The following Mermaid diagram illustrates a decision workflow for managing a suspected fowl cholera outbreak.

flowchart TD
    A[Suspected Fowl Cholera Outbreak], > B[Clinical Examination and Necropsy]
    B, > C[Collect Samples: Liver, Spleen, Bone Marrow]
    C, > D[Direct Microscopy: Bipolar Staining]
    D, > E[Presumptive Positive?]
    E, >|Yes| F[Culture on Blood Agar]
    E, >|No| G[Consider Differential Diagnoses]
    F, > H[Biochemical and Molecular Identification]
    H, > I[Antimicrobial Susceptibility Testing]
    I, > J[Initiate Flock Treatment]
    J, > K[Implement Biosecurity and Disinfection]
    K, > L[Vaccination Strategy for Remaining Flock]
    L, > M[Monitor for Recurrence]
    G, > N[Test for Salmonella, E. coli, Erysipelothrix]
    N, > O[Diagnosis Confirmed?]
    O, >|Yes| F
    O, >|No| P[Re-evaluate Clinical History]

Conclusion

Fowl cholera remains a significant cause of economic loss in poultry production worldwide. The fowl cholera causal agent, Pasteurella multocida, is a highly virulent bacterium capable of causing acute septicemia with high mortality. Effective disease management requires rapid diagnosis through culture and molecular methods, targeted antimicrobial therapy guided by susceptibility testing, and comprehensive control programs integrating biosecurity, vaccination, and carrier eradication. Continued surveillance for antimicrobial resistance and refinement of vaccine strategies are essential for sustainable control of this important avian pathogen.

References

[1] Glisson JR, Hofacre CL, Christensen JP. Fowl cholera. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020.

[2] Carter GR. Studies on Pasteurella multocida. I. A hemagglutination test for the identification of serological types. American Journal of Veterinary Research. 1955;16(60):481-484.

[3] Christensen JP, Bisgaard M. Fowl cholera. Revue Scientifique et Technique (International Office of Epizootics). 2000;19(2):626-637.

[4] Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters. 2006;265(1):1-10.

[5] Wilkie IW, Harper M, Boyce JD, Adler B. Pasteurella multocida: diseases and pathogenesis. Current Topics in Microbiology and Immunology. 2012;361:1-22.

[6] Carpenter TE, Snipes KP, Wallis D, Hird DW. Epidemiology of fowl cholera in California. Journal of the American Veterinary Medical Association. 1988;192(9):1269-1273.

[7] Shivaprasad HL. Fowl cholera. In: Saif YM, editor. Diseases of Poultry. 12th ed. Blackwell Publishing; 2008.

[8] Townsend KM, Boyce JD, Chung JY, Frost AJ, Adler B. Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. Journal of Clinical Microbiology. 2001;39(3):924-929.

[9] Kehrenberg C, Schwarz S. Occurrence and linkage of genes coding for resistance to sulfonamides, streptomycin, and chloramphenicol in bacteria of the genera Pasteurella and Mannheimia. FEMS Microbiology Letters. 2001;205(2):283-287.

[10] Bierer BW, Derieux WT. Immunologic response of turkeys to an attenuated Pasteurella multocida vaccine. Poultry Science. 1972;51(5):1542-1547. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.